DRAP allows import, manufacturing of Remdesivir


ISLAMABAD: Drug Regulatory Authority of Pakistan (DRAP) has issued registration letters for import and manufacturing of Remdesivir used for critically ill patients of COVID-19.

According to spokesman Ministry of National Health Services, on increasing demand, approvals are issued to two importers and 14 local manufacturers.

He said Remdesivir is approved for emergency use in a special emergency meeting in order to ensure early availability.

You May Also Like


ML-I railway project to strengthen ties b/w Pakistan, China: Rasheed

ISLAMABAD: Railways Minister Sheikh Rasheed Ahmed says ML-I


Huawei Pakistan presents donation of PPE to MOFA

ISLAMABAD: Huawei Pakistan Deputy CEO Ma Libing presented


Public sector schools opened in KP

PESHAWAR: The public sector schools have opened in all districts of